Compare IPST & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPST | GCTK |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | United States | United States |
| Employees | 21 | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 3.0M |
| IPO Year | N/A | 2011 |
| Metric | IPST | GCTK |
|---|---|---|
| Price | $3.48 | $0.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $164.00 | N/A |
| AVG Volume (30 Days) | 57.5K | ★ 601.2K |
| Earning Date | 04-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | $70.16 | N/A |
| Revenue Next Year | $60.33 | N/A |
| P/E Ratio | ★ $0.01 | $0.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $0.29 |
| 52 Week High | $15.08 | $15.90 |
| Indicator | IPST | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 30.39 |
| Support Level | $3.31 | $0.29 |
| Resistance Level | $6.71 | $1.02 |
| Average True Range (ATR) | 0.44 | 0.07 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 12.99 | 19.08 |
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.